Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Hong Kong Tech Press.
Press releases published on October 1, 2025
CRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress
ZUG, Switzerland and BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the acceptance of an abstract for …
AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19
- Meeting date aligns with prior guidance - - FDA to review AEON’s analytical development plan and initial data - IRVINE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a biopharmaceutical company …
Eva Live Inc. and Eightpoint Launch Strategic and Profit-Sharing Partnership to Deliver Scalable AI Business Intelligence Solutions Across Global Markets
Profit Sharing Partnership Highlights Proven Performance and Supports Company’s AI-Driven Monetization Strategy Los Angeles, CA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Eva Live Inc. ("Eva" or the "Company," OTCQB: GOAI), an AI-native performance marketing …
Datavault AI Signs MOU with Korea Aerospace University to Pioneer Digital Credentialing and Aerospace Innovation
BEAVERTON, Ore., Oct. 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- Datavault AI Inc. (NASDAQ: DVLT), a leader in AI-driven data visualization, valuation, and monetization, today announced it has signed a memorandum of understanding with Korea Aerospace …
Datavault AI Signs MOU with Korea Aerospace University to Pioneer Digital Credentialing and Aerospace Innovation
BEAVERTON, Ore., Oct. 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- Datavault AI Inc. (NASDAQ: DVLT), a leader in AI-driven data visualization, valuation, and monetization, today announced it has signed a memorandum of understanding with Korea Aerospace …
BLUZOR Exchange Upgrades Its 24/7 AI Wealth Assistant, Now Compatible with Mainstream Wallets
Denver, CO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- BLUZOR Exchange (Bluzor Digital Asset Exchange Ltd), a global leader in cryptocurrency trading and digital wealth management, today announced a significant upgrade to its 24/7 AI Wealth Assistant, now offering …
Cosmo5 launches to lead the AI omni-marketing revolution
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Today marks the official launch of Cosmo5, an international omni-channel marketing intelligence group built for the era of AI-driven brand engagement. Cosmo5, formerly known as Labelium Group, a digital agency …
Cosmo5 voit le jour pour mener la révolution du marketing omnicanal propulsé par l’IA
MONTRÉAL, 01 oct. 2025 (GLOBE NEWSWIRE) -- Aujourd’hui marque le lancement officiel de Cosmo5, un groupe international d’intelligence marketing omnicanal, conçu pour la nouvelle ère de l’engagement de marque alimenté par l’intelligence artificielle. …
EagleNXT Partners with UAVSICS to Expand Drone Solutions in Chile
Company continues to deploy sales and service capability in expanding Latin America region WICHITA, Kan., Oct. 01, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (dba, EagleNXT) (the “Company” or “EagleNXT”) (NYSE: UAVS), a leading provider of …
CIRA introduces Cyber Stack: a Canadian cybersecurity suite to protect organizations against cyber threats
OTTAWA, Ontario, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Today CIRA announced the launch of CIRA Cyber Stack, a new streamlined portfolio bringing together its suite of cybersecurity solutions under one unified name. Cyber Stack consolidates CIRA’s trusted …
CIRA présente Cyber Stack : une suite canadienne de cybersécurité pour protéger les organisations contre les cybermenaces
OTTAWA, Ontario, 01 oct. 2025 (GLOBE NEWSWIRE) -- CIRA a annoncé aujourd’hui le lancement de Cyber Stack de CIRA, un nouveau portefeuille simplifié qui regroupe sous un nom unique sa gamme de solutions de cybersécurité. Cyber Stack regroupe les services de …
Crane NXT Announces Appointment of Kim DiMaurizio as Senior Vice President and Chief People Officer
WALTHAM, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT) ("Crane NXT" or the "Company"), a premier industrial technology company, today announced it has appointed Kim DiMaurizio as Senior Vice President and Chief People Officer, …
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CLEVELAND, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule …
Digi Power X Achieves Tier III Certification for ARMS 200, Sets Near-Term Deployment Timeline and Provides September 2025 Operational Update
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. MIAMI, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“ …
Rezolve Ai Raises 2025 Guidance to $150M ARR and Initiates 2026 Guidance to $500M ARR Exit Rate as Strong Growth Shatters Analyst Forecasts
$6.3M H1 Revenue (+426% YoY) vs. $5.1M Consensus Gross Margin at 95.8% vs. 60–70% Consensus Adjusted EBITDA1 $(17.7)M vs. $(18.7)M Consensus 100+ Enterprise Customers2 Including Ferrero, H…
Spur Therapeutics to Present New Clinical Data on Its Gene Therapy Candidate in Gaucher Disease at Upcoming ESGCT Annual Congress
LONDON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced it will present new clinical data for avigbagene parvec (FLT201), its Phase 3-ready gene therapy candidate for Gaucher disease, at the European Society of Gene and Cell Therapy ( …
Arvinas to Present Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®
NEW HAVEN, Conn., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that two presentations, including one e-poster …
Immatics Appoints Venkat Ramanan as Chief Financial Officer
Houston, Texas and Tuebingen, Germany, October 1, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision targeting of PRAME, today announced the appointment of Venkat …
e-therapeutics Relaunches as Tangram Therapeutics and Unveils LLibra OS
Relaunch marks pivotal next step in the company’s growth, in anticipation of first CTA submission in Q4 2025. Introducing LLibra OS, a next-generation AI platform that accelerates discovery and evaluation of differentiated gene targets and siRNA design. …
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
SAN CARLOS, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that on September 24, 2025, the compensation committee of Biomea’ …